Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis

Summary

The primary objective of this trial is to evaluate the long-term safety of BI 695500 in adult patients with moderately to severely active rheumatoid arthritis (RA) who have successfully completed treatment in Trial 1301.1.

Timeline

Start

2013-05-31

Primary completion

2015-11-18

Completion

2016-11-07

Outcome

Outcome not reported

Stopped: “Substance discontinued”

Drugs

Indications